지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
이용수
등록된 정보가 없습니다.
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
Quality of life outcomes from the randomized trial of hyperthermic intraperitoneal chemotherapy following cytoreductive surgery for primary ovarian cancer (KOV-HIPEC-01)
Journal of Gynecologic Oncology
2022 .07
The role of HIPEC for advanced ovarian cancer : real world management
대한임상종양학회 학술대회지
2019 .02
Hyperthermic intraperitoneal chemotherapy as consolidation treatment of advanced stage ovarian cancer
Obstetrics & Gynecology Science
2021 .09
Incidence and treatment outcomes of uterine cervical cancer in Korea 1999– 2018 from the national cancer registry
Journal of Gynecologic Oncology
2023 .03
A phase II, open-label, non-randomized, prospective study assessing paclitaxel, carboplatin and metformin in the treatment of advanced stage ovarian carcinoma
Journal of Gynecologic Oncology
2023 .03
Effect of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy on relapse pattern in primary epithelial ovarian cancer: a propensity score based case-control study
Journal of Gynecologic Oncology
2018 .01
Can surgery boost the survival benefit of chemoradiotherapy in T1b1-T2a1 stage cervical cancer with lymph node metastasis? A population-based study
Journal of Gynecologic Oncology
2024 .05
Supragastric lesser sac: an insidious site for surgical exploration during the debulking surgery in advanced ovarian cancer
Journal of Gynecologic Oncology
2024 .05
Evaluation of secondary cytoreduction surgery in platinum-resistant ovarian cancer patients within three-line recurrent: a multicenter, randomized controlled study
Journal of Gynecologic Oncology
2024 .01
Robotic-assisted interval cytoreductive surgery in ovarian cancer: a feasibility study
Obstetrics & Gynecology Science
2020 .01
Incidence and treatment outcomes of ovarian carcinosarcoma from the national cancer registry of Korea
Journal of Gynecologic Oncology
2024 .01
A prospective randomized multicenter trial for lymphadenectomy in early- stage ovarian cancer: LOVE study
Journal of Gynecologic Oncology
2023 .05
Clinical Trial Protocol for HyNOVA: Hyperthermic and Normothermic intraperitoneal chemotherapy following interval cytoreductive surgery for stage III epithelial OVArian, fallopian tube and primary peritoneal cancer (ANZGOG1901/2020)
Journal of Gynecologic Oncology
2022 .01
Hyperthermic intraperitoneal chemotherapy with cisplatin and paclitaxel in advanced ovarian cancer: a multicenter prospective observational study
Journal of Gynecologic Oncology
2015 .01
Role of diagnostic laparoscopy in deciding primary treatment in advanced-stage ovarian cancer
Journal of Gynecologic Oncology
2023 .03
Trends in the incidence and survival outcomes of endometrial cancer in Korea: a nationwide population-based cohort study
Journal of Gynecologic Oncology
2024 .05
Indications and Effects of HIPEC
대한임상종양학회 학술대회지
2016 .02
Incidence and survival rates of primary uterine carcinosarcoma in Korea: a National Cancer Registry study
Journal of Gynecologic Oncology
2023 .01
Survival Effects of Cytoreductive Surgery for Refractory Patients after Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer
Yonsei Medical Journal
2020 .01
PREDICTIVE FACTORS OF POSTOPERATIVE MORBIDITY IN CYTOREDUCTIVE SURGERY AND HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY FOR PERITONEAL SURFACE MALIGNANCIES: A SINGLE INSTITUTE INDIAN STUDY
대한임상종양학회 학술대회지
2021 .06
0